EE836 Cost-Effectiveness of Zolbetuximab Plus Chemotherapy as First-Line Treatment for Advanced Gastric or Gastroesophageal Adenocarcinoma in Taiwan
2024 · Value in Health · 1 citations
https://doi.org/10.1016/j.jval.2024.10.1116
Y
YW Tsai
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
11
Papers
1
Citations
1
h-index
0
i10-index
YW Tsai is an academic researcher from National Yang Ming Chiao Tung University. The author has contributed to research in topics: Schizophrenia research and treatment & Gastric Cancer Management and Outcomes & Health Systems, Economic Evaluations, Quality of Life. The author has an h-index of 1, co-authored 10 publications.
Papers by this author
worksHSD112 Product Entry Sequence and Priority of Follow-on Drug Use: A Case Study of Second-Generation Antipsychotics with Long-Acting Injections
2024 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2024.03.2391
PCR131 Treatment Continuity, Adverse Events and Psychiatric Hospitalization for Incident Users of Second-Generation Antipsychotics Long-Acting Injections in Schizophrenia: One-Year Follow-up Study
2024 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2024.03.2010
EE674 Cost-Effectiveness of Pemigatinib for Patients With Advanced Intrahepatic Cholangiocarcinoma and FGFR2 Fusions/Rearrangements: 2024 FIGHT-202 Trial Final Results
2024 · Value in Health · 0 citations
https://doi.org/10.1016/j.jval.2024.10.954
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat